The Adlyxin (Lyxumia) market is witnessing steady growth over the forecast period, supported by growth in diabetes patient population, demand for once-daily injectables.
Read More
The Adcetris market is witnessing steady growth over the forecast period, supported by expansion into additional indications, increasing oncology biologics investment.
Read More
The Adbry/Adtralza market is witnessing steady growth over the forecast period, supported by growing eczema patient population, expansion into pediatric use.
Read More
The Adakveo market is witnessing steady growth over the forecast period, supported by growth in sickle cell patient population, expansion of access programs.
Read More
The Adagen market is witnessing steady growth over the forecast period, supported by advancements in genetic screening, rising rare disease awareness.
Read More
The Adacel market is witnessing steady growth over the forecast period, supported by growing adult immunization coverage, expansion of booster dose recommendations.
Read More
The Activase (Alteplase) market is witnessing steady growth over the forecast period, supported by growing global stroke incidence, faster emergency diagnostic capabilities.
Read More
The Actimmune market is witnessing steady growth over the forecast period, supported by rising diagnosis of rare immune disorders, increased access to specialty immunology centers.
Read More
The Acthrel market is witnessing steady growth over the forecast period, supported by increasing endocrine disorder prevalence, improved diagnostic accuracy demand.
Read More
The Acthib, Omnihib market is witnessing steady growth over the forecast period, supported by continued focus on infant immunization coverage, expansion in emerging economies.
Read More